I was able to find an interesting article from a trustworthy source on the open label extension. It can be construed both ways; an honest application to help patients and research (pumpers take), as well as a marketing tactic that's never published (bashers slant).

Clear as mud.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1200598/